Sourcing Disclosure: Licensed Bangladesh Global Sourcing Specialist facilitating global access under Named Patient Regulations.
Expert-reviewed clinical data for prescription-only medicine.
Global Oncology: Certified Pharmaceutical Sourcing & Biosimilars
Generic Oncology bridges the gap between innovation and Cancer Care Access by serving as a trusted authority for Global Oncology Solutions. We validate Oncology Biosimilars and Targeted Therapy Generics through strict Certified Pharmaceutical Sourcing, empowering the medical community with the rigorous clinical data needed to navigate modern treatments with confidence.
WHO GMP Standards
Cold Chain Supply
Global Express Shipping
Our latest and greatest
Adakras (Adagrasib) 200 mg Tablets | KRAS G12C Inhibitor
Alkixen 250 mg Capsule (Crizotinib) | First-Generation ALK & ROS-1 Positive NSCLC Therapy
Alpesib 150 mg (Alpelisib) Tablet | Phosphatidylinositol-3-Kinase (PI3K) Inhibitor
Ascimib 40 mg (Asciminib) Tablet | STAMP Inhibitor in PH+CML
Avalet 20 mg Tablet (Avatrombopag) | Second Generation of TPO Receptor Agonists (TPO-RAs)
Latest Blog and News
Storing and Handling Oral Oncology Medications at Home
March 30, 2026
Molecular Mechanisms of Synthetic Lethality: A Clinical Review of PARP Inhibition in BRCA-Mutated Malignancies
March 28, 2026
Medically Reviewed by: Dr. Salma Elreedy, Clinical Oncologist, Sphinx Cure Oncology Center. Fact-Checked by: Generic Oncology Editorial Team. Synthetic lethality…
Supportive and Palliative Oncology: Clinical Protocols for Quality of Life
March 26, 2026
Protocol Overview Historically, the discipline of clinical oncology maintained a singular, aggressive focus on tumor eradication. The primary metric of…
Evolving Production Standards and Accessibility in Generic Oncology Therapeutics
March 25, 2026
We have moved beyond the era where cancer care was defined strictly by high-cost, exclusive branded drugs accessible only to…
Strategies for Managing and Reducing Cancer Medication Costs: A 2026 Guide
March 23, 2026
The financial burden of cancer medication costs is often described by the medical community as “Financial Toxicity.” This is not…
The Science of Identifying High-Quality Generic Oncology Medicines
March 21, 2026
In the year 2026, the global oncology market is saturated with options. While the availability of generic medications has made…
Why Genericoncology
We Source from the WHO GMP-certified manufacturers
Drugs are Reviewed By Licensed Oncologists
We Work Only With the Valid Prescriptions
We Guarantee 100% Secure Payment
Featured Categories
